Parabilis Medicines, Inc. (PBLS)

30.18 +0.98 (+3.36%) USD  |  NASDAQ  |  Jul 07, 16:00
29.75 -0.43 (-1.42%) After-Hours: 20:00
More

Parabilis Medicines EPS Diluted (Quarterly) : -0.5999 for March 31, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for PBLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
March 31, 2026 -0.5999
Date Value
March 31, 2025 -0.4072

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Moderna, Inc. -3.40
Kailera Therapeutics, Inc. -0.6087
Arrowhead Pharmaceuticals, Inc. -0.932
Athersys, Inc. --
Oncolytics Biotech, Inc. -0.0823

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -45.32M
Total Expenses (Quarterly) 45.32M
Enterprise Value 3.989B
Earnings Yield -3.34%